SC 13G Filing

Company

LIGAND PHARMACEUTICALS INC

Filed

December 26, 2012

Accession Number

0001214659-12-005641

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →